CLINICAL_TRIALS
trial_result
· 2024-01-03
Clinical Trial Update: Immunogenicity After COVID-19 Vaccines in Adapted Schedules [Phase 4]
Summary
Phase 4 trial update examining immunogenicity of COVID-19 vaccines with adapted schedules; completed study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Universiteit Antwerpen | Conditions: Coronavirus Disease 2019, COVID-19 | Phase 4 | Status: COMPLETED